Cytokinetics, (CYTK) Stock Forecast & Price Prediction

Estimation of the future price movement of Cytokinetics, stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target

Current $33.46

Concensus $60.71

Low $45.00

Median $60.00

High $75.00

Based on analysts projections #CYTK is expected to experience a positive growth trajectory over the next year.

The current average CYTK price target, as estimated by these analysts, is $60.71.

The predictions for the future CYTK stock price range from a low of $45.00 to a high of $75.00, highlighting the variability of market expectations for CYTK.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

CYTK stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Needham December 23, 2022 Buy 58.00 45.59
Truist Financial December 20, 2022 Buy 60.00 45.22
Dane Leone
Raymond James
August 23, 2022 Buy 63.00 52.17
Yasmeen Rahimi
Piper Sandler
June 9, 2022 Buy 72.00 38.84
Joseph Pantginis
H.C. Wainwright
April 30, 2022 Buy 75.00 39.87
Carter Gould
December 20, 2021 Buy 52.00 39.50
Dane Leone
Raymond James
November 18, 2021 Buy 54.00 40.73
Jeffrey Hung
Morgan Stanley
October 8, 2021 Buy 45.00 38.01

Cytokinetics, (CYTK) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Cytokinetics, is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.


Financial Scores

Updated on: 07/12/2023

Altman Z-Score: -3.5

Piotroski Score: 1.0

ESG Score

Updated on: 07/12/2023

Environmental: 53.4

Social: 64.6

Governance: 60.6

Financial Health

Updated on: 07/12/2023

DCF: Strong Buy

ROE: Strong Buy

ROA: Sell

Debt to equity ratio: Strong Sell

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Sell

CYTK Discounted Cash Flow

Updated on: 07/12/2023

Discounted Cash Flow Value

Current Price

CYTK Revenues by Segment

Updated on: 07/12/2023

Research And Development

Revenue from Contract with Customer, Excluding Assessed Tax

CYTK Revenues by Region

Updated on: 07/12/2023

No available data

CYTK Notes Due

Updated on: 07/12/2023


There are no data to display

Cytokinetics, (CYTK) Social Sentiments

Monitoring bullish and bearish sentiments towards Cytokinetics, on Twitter and Stocktwits could help to forecast an upward or downward trend in Cytokinetics, stock price.

No social results for CYTK

Cytokinetics Stock Forecast: A Promising Future for a Leading Biopharmaceutical Company

Cytokinetics, Inc., a biopharmaceutical company operating in the United States, engages in the discovery, research, and development of muscle activators and inhibitors. With its stock ticker CYTK listed on various stock exchanges such as NASDAQ GS, over the years, the company has emerged as a leading player in its field. In this article today, we'll discuss Cytokinetics' outlook with respect... Read more